JANX
Price
$34.69
Change
-$0.05 (-0.14%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
2.09B
100 days until earnings call
Intraday BUY SELL Signals
LGND
Price
$206.36
Change
+$2.84 (+1.40%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
4.06B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JANX vs LGND

Header iconJANX vs LGND Comparison
Open Charts JANX vs LGNDBanner chart's image
Janux Therapeutics
Price$34.69
Change-$0.05 (-0.14%)
Volume$29.15K
Capitalization2.09B
Ligand Pharmaceuticals
Price$206.36
Change+$2.84 (+1.40%)
Volume$2.73K
Capitalization4.06B
JANX vs LGND Comparison Chart in %
JANX
Daily Signal:
Gain/Loss:
LGND
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JANX vs. LGND commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a StrongBuy and LGND is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 27, 2025
Stock price -- (JANX: $34.74 vs. LGND: $203.52)
Brand notoriety: JANX and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 221% vs. LGND: 115%
Market capitalization -- JANX: $2.09B vs. LGND: $4.06B
JANX [@Biotechnology] is valued at $2.09B. LGND’s [@Biotechnology] market capitalization is $4.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 2 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 2 green, 3 red.
According to our system of comparison, LGND is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 4 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • JANX’s TA Score: 4 bullish, 4 bearish.
  • LGND’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, JANX is a better buy in the short-term than LGND.

Price Growth

JANX (@Biotechnology) experienced а +19.71% price change this week, while LGND (@Biotechnology) price change was -1.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.60%. For the same industry, the average monthly price growth was -1.29%, and the average quarterly price growth was +72.73%.

Reported Earning Dates

JANX is expected to report earnings on Mar 06, 2026.

LGND is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+4.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($4.06B) has a higher market cap than JANX($2.09B). LGND YTD gains are higher at: 89.939 vs. JANX (-35.114). LGND has higher annual earnings (EBITDA): -45.94M vs. JANX (-142.8M). JANX has more cash in the bank: 996M vs. LGND (255M). LGND has less debt than JANX: LGND (5.74M) vs JANX (22.2M). LGND has higher revenues than JANX: LGND (188M) vs JANX (439K).
JANXLGNDJANX / LGND
Capitalization2.09B4.06B52%
EBITDA-142.8M-45.94M311%
Gain YTD-35.11489.939-39%
P/E RatioN/A90.82-
Revenue439K188M0%
Total Cash996M255M391%
Total Debt22.2M5.74M387%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXLGND
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signal:
Gain/Loss:
LGND
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIVBX19.840.22
+1.12%
American Funds International Vntg 529-C
GSSMX36.48N/A
N/A
Goldman Sachs Small Cap Value A
SVUIX40.39N/A
N/A
NAA SMid Cap Value Institutional
ACIHX70.34N/A
N/A
American Century Growth G
BFSIX27.03N/A
N/A
BFS Equity Institutional

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with NUVL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+10.18%
NUVL - JANX
47%
Loosely correlated
+0.30%
APGE - JANX
43%
Loosely correlated
+4.52%
CGON - JANX
41%
Loosely correlated
+4.48%
SKYE - JANX
41%
Loosely correlated
-1.54%
XNCR - JANX
41%
Loosely correlated
+3.11%
More